Case Study: Xarelto Lawsuit Information
Xarelto Lawsuit Information
The lawsuits on Xarelto states that the manufacturer failed to:
State that there is no antidote to prevent the bleeding from Xarelto.
State there could be rise in severe bleeding while taking Xarelto.
Conduct full investigations concerning the safety risks of Xarelto.
Give enough warnings about the safety risks that are associated with Xarelto.
The manufacturer also overdid the promotion on the drug therefore endangering millions of lives through the huge sales made.
Lawsuit Update, February 2016.
The FDA investigated if results used to approve Xarelto in the clinical trial (ROCKET AF trial) were genuine and still valid. The clinical trial, was to compare the effectiveness of Xarelto to those of Warfarin and showed
The lawsuits on Xarelto states that the manufacturer failed to:
State that there is no antidote to prevent the bleeding from Xarelto.
State there could be rise in severe bleeding while taking Xarelto.
Conduct full investigations concerning the safety risks of Xarelto.
Give enough warnings about the safety risks that are associated with Xarelto.
The manufacturer also overdid the promotion on the drug therefore endangering millions of lives through the huge sales made.
Lawsuit Update, February 2016.
The FDA investigated if results used to approve Xarelto in the clinical trial (ROCKET AF trial) were genuine and still valid. The clinical trial, was to compare the effectiveness of Xarelto to those of Warfarin and showed